Literature DB >> 20013359

Incidental finding of an 11C-acetate PET-positive multiple myeloma.

Sang Mi Lee1, Tae Sung Kim, Jeong Won Lee, Hyun Woo Kwon, Yong Il Kim, Se Hun Kang, Seok Ki Kim.   

Abstract

Multiple myeloma is a malignancy of plasma cells. The (18)F-FDG PET findings of multiple myeloma have been reported previously. However, the (11)C-acetate PET findings have not been clarified. Here, we report a case of multiple myeloma detected with (11)C-acetate PET in a 51-year-old male patient with known hepatocellular carcinoma. The patient was admitted for management of a pathologic fracture of the right tibia. Imaging workup including X-ray, magnetic resonance image, bone scintigraphy; (18)F-FDG led to a suspicion of metastatic bony lesions. Further, these lesions showed increased uptake on (11)C-acetate PET. Wide excision of the right tibia was performed, and histopathological examination of the lesion confirmed multiple myeloma. This case illustrates the characteristic (11)C-acetate PET findings of multiple myeloma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20013359     DOI: 10.1007/s12149-009-0325-6

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  4 in total

1.  (11)C-acetate as a new biomarker for PET/CT in patients with multiple myeloma: initial staging and postinduction response assessment.

Authors:  Chieh Lin; Chi-Lai Ho; Shu-Hang Ng; Po-Nan Wang; Yenlin Huang; Yu-Chun Lin; Tzung-Chih Tang; Shu-Fan Tsai; Alain Rahmouni; Tzu-Chen Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-10-16       Impact factor: 9.236

2.  The clinical use of PET with (11)C-acetate.

Authors:  Ilaria Grassi; Cristina Nanni; Vincenzo Allegri; Joshua James Morigi; Gian Carlo Montini; Paolo Castellucci; Stefano Fanti
Journal:  Am J Nucl Med Mol Imaging       Date:  2011-12-15

3.  11C-acetate positron emission tomography is more precise than 18F-fluorodeoxyglucose positron emission tomography in evaluating tumor burden and predicting disease risk of multiple myeloma.

Authors:  Miao Chen; Wenjia Zhu; Jianhua Du; Chen Yang; Bing Han; Daobin Zhou; Li Huo; Junling Zhuang
Journal:  Sci Rep       Date:  2021-11-12       Impact factor: 4.379

Review 4.  Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma.

Authors:  Christos Sachpekidis; Hartmut Goldschmidt; Antonia Dimitrakopoulou-Strauss
Journal:  Molecules       Date:  2019-12-29       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.